Melanoma of Unknown Primary
📧 Sign up to get email alerts when something new happens for Melanoma of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases [Phase 1]
Phase 1 trial evaluating stereotactic radiosurgery, NovoTTF-200M, and immune checkpoint inhibitors for melanoma brain metastases was termina…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases [Phase 1]
This phase 1 study assessed pembrolizumab in combination with stereotactic radiosurgery for patients with brain metastases from melanoma or …
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement [Phase 2]
A Phase 2 trial testing the combination of encorafenib and binimetinib before surgery for melanoma with lymph node involvement has been term…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma [Phase 2]
A Phase 2 study compares the combination of ipilimumab and nivolumab versus ipilimumab alone in advanced melanoma, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery [Phase 3]
This is a Phase 3 clinical trial update comparing ipilimumab to high-dose interferon alfa-2b in patients with resected high-risk Stage III–I…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.